Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Belinda J Hall

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
European Journal of Pharmacology|April 21, 2005
6-Methylflavanone, a more efficacious positive allosteric modulator of gamma-aminobutyric acid (GABA) action at human recombinant alpha2beta2gamma2L than at alpha1beta2gamma2L and alpha1beta2 GABA(A) receptors expressed in Xenopus oocytesBelinda J Hall, Mary Chebib, Jane R Hanrahan, et al.
European Journal of Pharmacology|April 23, 2004
Flumazenil-independent positive modulation of gamma-aminobutyric acid action by 6-methylflavone at human recombinant alpha1beta2gamma2L and alpha1beta2 GABAA receptorsBelinda J Hall, Mary Chebib, Jane R Hanrahan, et al.
Neurochemical Research|October 1, 2013
Modulation of ionotropic GABA receptors by 6-methoxyflavanone and 6-methoxyflavoneBelinda J Hall, Nasiara Karim, Mary Chebib, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Semisynthetic preparation of amentoflavone: A negative modulator at GABA(A) receptorsJane R Hanrahan, Mary Chebib, Neil L M Davucheron, et al.
The Cochrane Database of Systematic Reviews|December 14, 2011
Interventions for preventing obesity in childrenElizabeth Waters, Andrea de Silva-Sanigorski, Belinda J Hall, et al.
Lung Cancer (Amsterdam, Netherlands)|June 26, 2007
Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancerJose R Pereira, Luis Fein, Auro Del Giglio, et al.
Journal of Bone and Mineral Metabolism|February 27, 2007
Comparison of raloxifene and bisphosphonates based on adherence and treatment satisfaction in postmenopausal Asian womenEllewellyn G Pasion, Shanmugam K Sivananthan, Annie Wai-Chee Kung, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
European Journal of Pharmacology|April 21, 2005
6-Methylflavanone, a more efficacious positive allosteric modulator of gamma-aminobutyric acid (GABA) action at human recombinant alpha2beta2gamma2L than at alpha1beta2gamma2L and alpha1beta2 GABA(A) receptors expressed in Xenopus oocytesBelinda J Hall, Mary Chebib, Jane R Hanrahan, et al.
European Journal of Pharmacology|April 23, 2004
Flumazenil-independent positive modulation of gamma-aminobutyric acid action by 6-methylflavone at human recombinant alpha1beta2gamma2L and alpha1beta2 GABAA receptorsBelinda J Hall, Mary Chebib, Jane R Hanrahan, et al.
Neurochemical Research|October 1, 2013
Modulation of ionotropic GABA receptors by 6-methoxyflavanone and 6-methoxyflavoneBelinda J Hall, Nasiara Karim, Mary Chebib, et al.
Bioorganic & Medicinal Chemistry Letters|June 26, 2003
Semisynthetic preparation of amentoflavone: A negative modulator at GABA(A) receptorsJane R Hanrahan, Mary Chebib, Neil L M Davucheron, et al.
The Cochrane Database of Systematic Reviews|December 14, 2011
Interventions for preventing obesity in childrenElizabeth Waters, Andrea de Silva-Sanigorski, Belinda J Hall, et al.
Lung Cancer (Amsterdam, Netherlands)|June 26, 2007
Gemcitabine administered as a short infusion versus a fixed dose rate in combination with cisplatin for the treatment of patients with advanced non-small cell lung cancerJose R Pereira, Luis Fein, Auro Del Giglio, et al.
Journal of Bone and Mineral Metabolism|February 27, 2007
Comparison of raloxifene and bisphosphonates based on adherence and treatment satisfaction in postmenopausal Asian womenEllewellyn G Pasion, Shanmugam K Sivananthan, Annie Wai-Chee Kung, et al.
Pageof 1